Covance May 2026

It is an Angiotensin II Receptor Blocker (ARB) that relaxes blood vessels to lower pressure and ease heart strain.

Formerly known as Covance Inc., this company is a major Contract Research Organization (CRO) that manages clinical trials and laboratory testing. COVANCE

Managing phases I–IV of drug development for pharmaceutical and biotech firms. It is an Angiotensin II Receptor Blocker (ARB)

This medication is unsafe during pregnancy and can cause serious harm to an unborn baby. COVANCE